A a Comparative Study of Quality Control Testing on Candesartan Cilexetil Conventional Tablets in Iraq

Abstract

Objective: The present study was performed to compare the quality of conventional tablets loaded with candesartan cilexetil. The selected candesartan cilexetil tablets were commercialized in the Iraq market and produced by different companies. 
 Methods: Different batches of candesartan cilexetil oral tablets (the concentration of candesartan was 8 mg) were subjected to quality control tests. Tests included weight variation, friability, hardness, drug content, disintegration time and in vitro release study. The protocols of these tests were performed according to USP pharmacopeia.
 Results: The results, in this study, revealed that all the used batches of candesartan cilexetil oral tablets complied with the specification of USP pharmacopeia for weight uniformity, friability value (% loss) was<1. Hardness results of the tablets were 4.9-6.6 Kg/cm2, which was within the required limits (i.e. 4-8 Kg/cm2). Disintegration time was<15 min in both Simulated Gastric Fluid (SGF) and Simulated Intestinal Fluid (SIF). The percentage of drug content in all marketed tablets was found between 96.2 % and 99.8 %, reflecting compliance with the pharmacopeia limits (i.e. 85-115 %). An in vitro release study indicated that the release of all marketed tablets exceeds 80 % within 15 min.
 Conclusion: All the studied tablets, loaded with candesartan cilexetil, were produced within the standard criteria of tablet production. The quality control analysis of the selected tablets, in this study, revealed satisfactory pharmaceutical properties (including safety and effectiveness) that comply within the limits of USP pharmacopeia.

Design, Optimization and In vitro Evaluation of Mesalazine 400 mg Delayed Release Tablet for Colon Specific Delivery

“…In several prior studies, a hardness value between 5 to 7 kg/cm 2 was used as optimum amount for developing tablet formulations. 20,21 However, in current study as the formulated core tablets will be subjected to coating process, a hardness value of 7-8 kg/cm 2 was desired so that the tablets can withstand the coating stress. Since the intention of the formulation was to deliver the drug molecule effectively at colon, it was intended to have a maximum amount of drug release which was considered as response 2.…”

Formulation, Analysis and Validation of Nanosuspensions-Loaded Voriconazole to Enhance Solubility

“…Pharmaceutical nanosuspensions are aqueous dispersions of insoluble drug particles that are nanosized and stabilized by surfactants. Nanoparticles, on the other hand, are drug carriers that are either polymeric or lipid colloidal [3][4][5]. When a drug molecule has several limitations, such as the inability to form salt, high molecular weight, dose, log P and melting point, nanosuspension is the only choice accessible [6].…”

Development, Evaluation and Rp-HPLC Method for Simultaneous Estimation of Quercetin, Ellagic Acid and Kaempferol in a Polyherbal Formulation

“…Standardization and quality control of plant-based herbal medication by utilizing modern apparatus and utilization of suitable standards is constantly emphasized by WHO [6]. Quality control of herbal medication is a significant process of the pharmaceutical companies, which is mentioned as all should be embraced to promise the purity and uniformity of marketed pharmaceuticals [7]. The development of this polyherbal formulation into a suitable drug delivery system in the form of a tablet was looked to be of suitable pharmacopeial quality and would have comparable release profiles of the conventional dosage form.…”